Medical Blog About Treatment Abroad

Glioblastoma (GBM or glioblastoma multiforme) is considered one of the most aggressive forms of brain cancer. Newly diagnosed GBM patients, according to global statistics, number approximately 3-5 per 100,000 population annually. Specifically, in Germany, data from the 2022 national cancer registries show that about 3,130 women...

With an annual increase in incidence of 0.5-1.0%, pancreatic cancer is rapidly approaching the status of the second leading cause of cancer mortality by 2030. Such dynamics make the issue of finding effective treatment methods critically important for modern oncology. Pancreatic cancer is also infamous for its resistance to conventional...

Standard therapy for glioblastoma is the combination of surgical removal of the tumor, chemo- or radiation therapy. Average life expectancy after diagnosis with standard treatment of glioblastoma is 15-17 months, and the 5-year survival rate does not exceed 5-10%. Today, supplementing the standard treatment protocol with innovative...

Cancer is one of the leading causes of death among humanity, with approximately 20 million new cases each year and 9.7 million cancer deaths worldwide. About 1 in 5 people will develop cancer in their lifetime, making it a global health concern. There are different treatment options available, but no one can guarantee a complete cure.

Immune-based therapy is an innovative method of cancer treatment, and one of the most promising innovations is dendritic cell therapy. This radical approach utilizes the strength of the patient's immune system to attack carcinoma and destroy tumor cells. The 2011 Nobel Prize in Medicine, awarded to Ralph M. Steinman as a discoverer...

One or two decades ago, a cancer diagnosis was almost equated to death. Nowadays, due to the fast development of healthcare, numerous oncological diseases can be cured. Nevertheless, the cancer burden is still high in Europe. The European Cancer Information System (ECIS) states that in 2022 around 4.1 million new cases of cancer were...

A benign brain tumor is a non-cancerous, slow-growing mass of cells in and around the brain tissue. It accounts for nearly 72% of all primary brain neoplasms, with an incidence of roughly 17.69 per 100,000 people. Non-malignant primary central nervous system (CNS) tumors are more frequently diagnosed in females, with research indicating that...

In Germany, prostate cancer is treated in large multidisciplinary university hospitals, as well as specialized centers of PCa treatment and radiation therapy. With over 50 specialized centers achieving 5-year survival rates above 90% for localized disease, Germany offers advanced therapeutic options. The availability of robotic surgical...